DIU de rythmologie et stimulation cardiaque. Orateur : Serge BOVEDA Le 25 janvier 2012
|
|
- Morris Powers
- 8 years ago
- Views:
Transcription
1 DIU de rythmologie et stimulation cardiaque Titre : Fibrillation atriale paroxystique : ablation, résultats, complications Orateur : Serge BOVEDA Le 25 janvier 2012
2 Fibrillation Atriale Paroxystique : ablation, résultats, complications DIU Rythmologie Paris, le 25/01/12 s.boveda@clinique-pasteur.com
3 1 A disease with bad consequences RR de patients en FA comparé avec des patients sans FA ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation Population de FA X 2 entre 1995 et 2030 Go et al, JAMA 2001
4 1 Afib ablation : is it THE Solution? Mortality, Morbidity, and Quality of Life after Circumferential Pulmonary Vein Ablation for Atrial Fibrillation Outcomes from a Controlled Nonrandomized Long-term Study Pappone C et al. J Am Coll Cardiol 2003 Pulmonary vein ablation improves mortality, morbidity, and QoL as compared with medical therapy Our findings pave the way for randomized trials to prospect a wider application of ablation for AF All patients should be ablated...
5 2 Afib ablation : theoretical aspects Haissaguerre M et al. NEJM 1998
6 2 Afib ablation : theoretical aspects Foyer FA
7 2 Afib ablation : theoretical aspects
8 2 Afib ablation : theoretical aspects * * * * *
9 Strategy of Afib ablation Initiation = Paroxysmal = Persistent Sustained = LA substrate Primary focuses (95% PV) Focal ablation Altered Tissue Linear lesions
10 2 Afib ablation : theoretical aspects
11 2 Afib ablation : theoretical aspects 3-D + Irrigated Single shot tools Kuck, Pappone Pappone Pappone Lasso + Irrigated Bordeaux 2000 Bordeaux 1999 Bordeaux 2001
12 3 Afib ablation : technical aspects Decapolar Lasso Catheter for PV mapping
13 3 Afib ablation : technical aspects VPSD VPSG VPID VPIG
14 3 Afib ablation : technical aspects Kato R. et al. Circulation 2003;107:
15 Bilan anatomique des veines pulmonaires Angiographie per-procédure, IRM, TDM multibarrettes +++ :
16 3 Afib ablation : technical aspects All 4 veins deconnection assessed by the absence of PV potential at the ostium of each vein Control of the 4 veins just before removing the catheters (frequent recurrences +++)
17 Right superior PV before/after RF
18 Left superior PV before/after RF
19 LIPV disconnection
20
21
22
23
24 Follow-up - Holter just after the procedure, after 3, 6 and 12 months - Warfarin at least during 6 months in case of afib recurrences
25 Why still so much recurrences?
26 3 Afib ablation : technical aspects Navigation systems Nowadays: Carto 3
27 Circumferential PVI Arentz T. Circulation 2007
28 PV Isolation: the larger the better? 110 Patients Ostial segmental PVI = small isolation Circumferential Isolation = large isolation Arentz et al. Circulation 2007
29 PV Isolation: the larger the better!!! Arentz et al. Small or large isolation areas around the PVs. Circulation 2007
30 3 Afib ablation : technical aspects Single shot tools for paroxysmal AFib
31 PVAC : pulmonary vein ablation catheter I III V1 PVAC 1 PVAC 2 PVAC 3 PVAC 4 PVAC 5 CS prox CS dist 1 Minute Ablation time
32 PAF Typical baseline ECG
33 Afib coming from RSPV
34 LSPV before RF ablation
35 LSPV after first RF application : 1 st degree PV block
36 LSPV after RF ablation
37 Pacing inside LSPV showing LA dissociation
38 Pacing inside LIPV : still connected
39 LIPV pre RF ablation
40 LIPV post RF ablation
41 RSPV pre RF ablation
42 RSPV dissociation after RF ablation
43 RIPV pre RF ablation
44 RIPV post RF ablation
45 3 Afib ablation : technical aspects Cryoablation - Methods 240 sec per application 23 mm 28 mm At least 2 applications per vein with good occlusion achieved during venography, through <-40 Size of the balloon : - 28 mm or 23 mm according to : the PV diameter (CT scan > or < 15/16 mm), Gender: Women, low BMI : 23 mm ++ Size of the RSPV
46
47 Cryoablation is it superior to radiofrequency ablation? Cryolesion1 week (dog, LV) Freezor 4 mm, -75 C, 240 s Less endocardial disruption Preservation of underlying tissue architecture reduce platelet and clotting activation and thrombus formation > thromboembolism Khairy P, et al. Circulation. 2003;107:
48 If the diameter of the PVs is >15 mm 28 mm balloon
49 LSPV /Achieve
50 Achieve in the LSPV, isolation at 35 s freeze during CS pacing
51 (1) Paroxysmal AF, Achieve in the LSPV, without pacing - Where is the A potential? - Where is the venous potential? where is the ventricular potential?
52 (2) During cryo ablation at 15 sec
53 4 Afib ablation : results Parox AF ablation: success rate Meta-analysis of catheter ablation studies Ablation method Patients Paroxysmal AF SHD 6 mo cure 6 mo OK Linear % 26 % 33 % 55 % Focal % 35 % 54 % 71 % Isolation 2, % 36 % 62 % 75 % Circumferential (all) 15, % 37 % 64 % 74 % Circumferential (LACA, WACA) 2, % 37 % 59 % 72 % Circumferential (PVAI) 11, % 42 % 67 % 76 % Substrate ablation (CFAE) % 49 % 75 % 87 % Total 23, % 55 % 63 % 75 % The VeniceChart international consensus document
54 PAF Ablation : Randomized Studies AF - ESC Guidelines, EHJ 2010
55 Study Design of the STOP-AF Trial Inclusions: Patients >2 AF episodes in 2 months w ECG doc. of 1 Rx Failure of > 1 AA Rx Follow- up 1,3,6,9, &12 mo Holters Weekly TTMs
56 Primary Effectiveness Analysis Treatment Success days Treatment success (%) Blanked CRYO 69.9% 114/163 P<0.001) DRUG Rx 7.3% 6/ KM estimate 68.6% (SE 3.9%) Days vs 7.3% (SE 2.9%)
57 4 Afib ablation : CP results
58 4 Afib ablation : CP results Success without AAD Success with AAD Paroxysmal Afib Persistent/ Afib (1 year) 72 % 80 % 52 % 63 %
59 4 Afib ablation : elderly patients Zado et al, J Cardiovasc Electrophysiol 2008
60 4 Afib ablation : athletes patients In patients with documented focal induction of nonpermanent AF and absence of structural heart disease, PVI is as effective in athletes as in other patients Koopman P, Europace 2011
61 5 Afib ablation : complications Accès Percutané Complications «locales» : Fistule artério/veineuse, Hématome fémoral Manipulation cathéters / Ponction Transeptale Perforation cardiaque / Tamponnade ; Perforation du sinus coronaire ; lésion aortique Energie Délivrée Perforation cardiaque / Tamponnade ; Lésion valvulaire ; AVC ; Fistule oesophagienne
62 5 Afib ablation : complications Verma A et al. ( Circulation 2005;112: ) Global risk between 2 and 3% (higher for persistent Afib?...)
63 5 Afib ablation : complications AVC : incidence = 0 à 4%... ACT (per-op + post-op) Surveillance clinique per-op + post-op Stroke center / Fibrinolyse Troughton R, Heart 2003 Dixit S, Heart Rhythm 2007
64 5 Afib ablation : complications Tamponnade : incidence = 1.2 à 6%... Drainage sous-xyphoïdien Chirurgie +++ Wu R, J Cardiovasc Electrophysiol 2002
65 5 Afib ablation : complications Fistule atrio œsophagienne : incidence < 0.25% / Mortalité = 50%... Sra J, J Interv Card Electrophysiol 2008 Dixit S, Heart Rhythm 2007
66 5 Afib ablation : complications PV stenosis : up to 15% / Severe >70% : 1-3% Sra J, J Interv Card Electrophysiol 2008
67 5 Afib ablation : complications Asymptomatic PV stenosis 3 months after ablation
68 6 Looking at the Guidelines?
69 6 Looking at the Guidelines
70 7 Should we ablate before? This suggests that the selection of patients for the invasive strategy should be considered at an earlier stage of the disease, even before AAD Europace 2011
71 Take Home Message 1. Symptomatic parox Afib ablation after AAD failure is a IIa / I indication with a 75% success and 2-3% complication rates 2. Afib ablation is cost-effective in these patients 3. Persistent Afib ablation remains challenging, with long fluoro exposure time, higher morbidity and lower success rates 4. Afib type, absence of SHD, LA enlargement, LA fibrosis/srm seem to be important factors for a better outcome after ablation 5. try to ablate before Afib becomes persistent 6. at earlier stages of the disease 7. but not before AAD treatment : IIb indication
Ablation For Atrial Fibrillation. Bill Petrellis Electrophysiologist
Ablation For Atrial Fibrillation Bill Petrellis Electrophysiologist AF is the most common arrhythmia in the Western world Prevalence 1.1% in Australia conservative estimate - 240,000 June 2009 AF is an
More informationManagement of Symptomatic Atrial Fibrillation
Management of Symptomatic Atrial Fibrillation John F. MacGregor, MD, FHRS Associate Medical Director, Cardiac Electrophysiology PeaceHealth St. Joseph Medical Center, Bellingham, WA September 18, 2015
More informationHow do you decide on rate versus rhythm control?
How do you decide on rate versus rhythm control? Dr. Mark O Neill Consultant Cardiologist & Electrophysiologist Assumptions Camm et al. EHJ 2010;Sept 25 epub Choice of strategy: Criteria for consideration
More informationDISCLOSURE. Atrial Fibrillation Management An Evidence-based Approach OBJECTIVES BACKGROUND AFFIRM 9/16/2015
Death (%) Mortality (%) 9/16/2015 DISCLOSURE Atrial Fibrillation Management An Evidence-based Approach Jonathon Adams, MD, FHRS Relevant Financial Relationship(s) None Off Label Usage None OBJECTIVES What
More informationThe Decision Tree for Ablation Therapy in Atrial Fibrillation Colin Movsowitz, MD, FACC Cardiology Consultants of Philadelphia Director of Electrophysiology Einstein Medical Center Montgomery Co-Director
More informationAtrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial
Atrial Fibrillation Catheter Ablation versus Surgical Ablation Treatment: FAST A Two-Center Randomized Clinical Trial Lucas Boersma, WimJan van Boven, Alaaddin Yilmaz, Johannes Kelder, Maurits Wijffels
More informationHow do you decide on rate versus rhythm control?
Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study
More informationThe Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate
More informationVorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin
Vorhofflimmern und Schlaganfall Ablation, Antikoagulation, Vorhofohrverschluß was wann für wen? B. Keweloh Unfallkrankenhaus Berlin B. Keweloh 16.11.2013 Incidence of Atrial Fibrillation, Standard population
More informationHow should we treat atrial fibrillation in heart failure
Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città
More information2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them?
2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them? Gaetano Senatore DIVISION OF CARDIOLOGY HOSPITAL OF CIRIE
More informationAtrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology
Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of
More informationSporadic or short episodes of paroxysmal atrial fibrillation - still a need for antithrombotic therapy?
Sporadic or short episodes of paroxysmal atrial fibrillation - still a need for antithrombotic therapy? Carina Blomström Lundqvist Dept Cardiology, Uppsala University, Sweden Patterns of AF Terminates
More informationPresenter Disclosure Information
2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.
More informationCOVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence
More informationAtrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
More informationRecurrent AF: Choosing the Right Medication.
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department
More informationCombined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation. Ashkan Babaie MD Providence Portland Medical Center
Combined Epicardial and Endocardial Ablation for Treatment of Atrial Fibrillation Ashkan Babaie MD Providence Portland Medical Center 1 Disclosures None 2 Cox-Maze III The Godfather Cure rates > 95% in
More informationAtrial Fibrillation and Ablation Therapy: A Patient s Guide
Atrial Fibrillation and Ablation Therapy: A Patient s Guide ATRIAL FIBRILLATION CENTER AT UNIVERSITY OF ROCHESTER MEDICAL CENTER www.heart.urmc.edu 585-275-4775 INTRODUCTION Our goal at the Atrial Fibrillation
More informationHow to control atrial fibrillation in 2013 The ideal patient for a rate control strategy
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy L. Pison, MD Advances in Cardiac Arrhythmias and Great Innovations in Cardiology - Torino, September 28 th 2013
More informationRATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
More informationManagement of Atrial Fibrillation in Heart Failure
Disadvantages of AV Junction Ablation Persistent AFib- no AV synchrony Ongoing risk of thromboembolism Life-long dependency on pacemaker Comparison of LA Ablation vs. AVN Ablation LA Ablation AVN Ablation
More informationTreating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
More informationAtrial Fibrillation (AF) March, 2013
Atrial Fibrillation (AF) March, 2013 This handout is meant to help with discussions about the condition, and it is not a complete discussion of AF. We hope it will complement your appointment with one
More informationPalpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust
Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia
More informationNgaire has Palpitations
Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.
More informationAtrial Fibrillation Cardiac rate control or rhythm control could be the key to AF therapy
Cardiac rate control or rhythm control could be the key to AF therapy Recent studies have proven that an option of pharmacologic and non-pharmacologic therapy is available to patients who suffer from AF.
More informationFörmaksflimmer ablation - en uppdatering och guidelines. Carina Blomström Lundqvist, Dept.of Cardiology, Uppsala University Hospital.
Förmaksflimmer ablation - en uppdatering och guidelines Carina Blomström Lundqvist, Dept.of Cardiology, Uppsala University Hospital. Cardiac Surgery for AF management Maze I Maze II Maze III 1987-1992
More informationTechniques of Mapping and Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation
Aus dem Deutschen Herzzentrum Berlin Klinik für Innere Medizin/Kardiologie DISSERTATION Techniques of Mapping and Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation zur Erlangung des
More informationCatheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation
Catheter Ablation of Arrhythmogenic Foci as Treatment for Atrial Fibrillation Policy Number: Original Effective Date: MM.06.011 09/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration
More informationAtrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.
More informationCorporate Medical Policy
Corporate Medical Policy Catheter Ablation as a Treatment for Atrial Fibrillation File Name: Origination: Last CAP Review: Next CAP Review: Last Review: catheter_ablation_as_a_treatment_for_atrial_fibrillation
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Catheter Ablation as Treatment Page 1 of 29 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Catheter Ablation as Treatment Professional Institutional Original Effective
More informationManaging the Patient with Atrial Fibrillation
Pocket Guide Managing the Patient with Atrial Fibrillation Updated April 2012 Editor Stephen R. Shorofsky, MD, Ph.D. Assistant Editors Anastasios Saliaris, MD Shawn Robinson, MD www.hrsonline.org DEFINITION
More informationAtrial Fibrillation The Basics
Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation
More informationName of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation
Name of Policy: Transcatheter Ablation of Arrhythmogenic Foci as a Treatment of Atrial Fibrillation Policy #: 283 Latest Review Date: June 2015 Category: Medical Policy Grade: A Background/Definitions:
More informationIl destino dei pazienti dopo ablazione della fibrillazione atriale
Tigullio Cardiologia 2014 La terapia della fibrillazione atriale: Il destino dei pazienti dopo ablazione della fibrillazione atriale N. Bottoni Responsabile U.O.S. Aritmologia Interventistica, Az. Ospedaliera
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): April 26, 2011 Most Recent Review Date (Revised): January 27, 2015 Effective Date: April 1, 2015 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationProjected Number of Adults With AF in the US. Review the growing incidence and importance of AF in the population
Atrial Fibrillation Troy E. Rhodes, MD, PhD Division of Cardiovascular Medicine, Electrophysiology Ohio State University Medical Center Learning Objectives Review the growing incidence and importance of
More informationA focus on atrial fibrillation
A focus on atrial fibrillation Is being female really a risk factor for stroke? Dr Justin Mariani MBBS BMedSci PhD FRACP FCSANZ Consultant Cardiologist and Interventional Heart Failure Specialist Alfred
More informationIntroduction to Electrophysiology. Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center
Introduction to Electrophysiology Wm. W. Barrington, MD, FACC University of Pittsburgh Medical Center Objectives Indications for EP Study How do we do the study Normal recordings Abnormal Recordings Limitations
More informationTHE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological
More informationATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
More informationAtrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015
Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015 Disclaimer I have no relationships to disclose Do we have a cure for Atrial Fibrillation? The short
More informationDifficult Cases in Atrial Fibrillation. Ascot Cardiology GP Symposium April 2014
Difficult Cases in Atrial Fibrillation Ascot Cardiology GP Symposium April 2014 Atrial Fibrillation 1-2% general population 40-50yrs
More informationNational Medical Policy
National Medical Policy Subject: Policy Number: Catheter Ablation for Atrial Fibrillation NMP175 Effective Date*: May 2010 Update: July 2015 This National Medical Policy is subject to the terms in the
More informationThe intensity and duration of monitoring should be determined by the clinical need to establish the diagnosis
Cardiology and Vascular Medicine ESC Update Programme in Cardiology Rotterdam, June 12 th, 2012 Atrial Fibrillation ESC Guidelines: Paroxysmal Atrial Fibrillation Irene Savelieva St George s University
More informationAtrial fibrillation How is treatment changing? Charles Henrikson, MD Director, Electrophysiology Service 1 February 2014
Atrial fibrillation How is treatment changing? Charles Henrikson, MD Director, Electrophysiology Service 1 February 2014 Outline Introduction Natural history of afib and stroke Current risk stratification
More informationAnticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014
Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014 Atrial Fibrillation 2 Atrial Fibrillation The most common arrhythmia encountered
More informationCATHETER ABLATION for ATRIAL FIBRILLATION
CATHETER ABLATION for ATRIAL FIBRILLATION Atrial Fibrillation Clinic Dr. Richard Leather, Dr. Larry Sterns, Dr Paul Novak, Dr. Chris Lane Royal Jubilee Hospital Block 3 rd floor, Rm 343 1952 Bay Street
More informationManaging Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular
Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Mitral Regurgitation Anatomy Mechanisms of MR Presentation Evaluation Management Repair Replace Clip
More informationAtrial Fibrillation Management Across the Spectrum of Illness
Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,
More informationBIOSENSE WEBSTER NAVISTAR THERMOCOOL Catheter for Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation FDA review of P030031/S11
BIOSENSE WEBSTER NAVISTAR THERMOCOOL Catheter for Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation FDA review of P030031/S11 Benjamin C. Eloff, Ph.D. Division of Cardiovascular Devices
More informationNew in Atrial Fibrillation
New in Atrial Fibrillation September 2011 Stroke prevention more options Rhythm Control -drugs - alternatives to drugs; ablation Rate Control - pace + ablate A-FIB Dell Stroke Risk AFib Two Principles
More informationSurgeons Role in Atrial Fibrillation
Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)
More informationAddendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter
22 July 2010 EMA/CHMP/EWP/213056/2010 Addendum to the Guideline on antiarrhythmics on atrial fibrillation and atrial flutter Draft Agreed by Efficacy Working Party July 2008 Adoption by CHMP for release
More informationThe debate: Should all AF patients see an EP consultant?
The debate: Should all AF patients see an EP consultant? Pre-debate show of hands in favour of the motion The argument for the motion: Dr Nick Kelland The argument against the motion: Dr Andy McCoye Discussion
More informationLong term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial
Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial Camillo Autore Università di Roma Sapienza II Facoltà di Medicina e Chirurgia
More informationA Patient Guide to Atrial Fibrillation and Catheter Ablation
A Patient Guide to Atrial Fibrillation and Catheter Ablation Al-Sabah Arrhythmia Institute 1111 Amsterdam Avenue New York, NY 10025 Phone: 212-523-2400 Fax: 212-523-2571 www.stlukescardiology.org Printed
More informationRome, Italy December 4-7, 2012 Rome Cavalieri TIMETABLE
Rome, Italy December 4-7, 2012 Rome Cavalieri Monday, December 3 ROOM Terrazza Monte Mario PATIENT MANAGEMENT CONCEPTS AND CONTROVERSIES IN ELECTROPHYSIOLOGY BIOTRONIK International Fellows Program (IFP)
More informationNew Anticoagulation Options for Stroke Prevention in Atrial Fibrillation. Joy Wahawisan, Pharm.D., BCPS April 25, 2012
New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation Joy Wahawisan, Pharm.D., BCPS April 25, 2012 Stroke in Atrial Fibrillation % Stroke 1991;22:983. Age Range (years) CHADS 2 Risk
More informationCurrent ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey
Europace (215) 17, 1596 16 doi:1.19/europace/euv2 EP WIRE Current techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey Nikolaos Dagres 1 *, Maria Grazia
More informationAtrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
More informationElectrocardiographic Issues in Williams Syndrome
Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital
More informationDISCLOSURES. I am a consultant for Biosense Webster St Jude Medical
Ablation vs. Amiodarone for Treatment of Atrial Fibrillation in Patients with Congestive Heart Failure and an Implanted ICD/CRTD (AATAC-AF in Heart Failure) ClinicalTrials.gov Identifier: NCT00729911/
More informationTABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours)
Clinical Practice Guidelines for the Management of Patients With Atrial Fibrillation Deborah Ritchie RN, MN, Robert S Sheldon MD, PhD Cardiovascular Research Group, University of Calgary, Alberta Partly
More informationNew Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013
New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7
More informationAtrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center
Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long
More informationAntiplatelet and Antithrombotics From clinical trials to guidelines
Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories
More informationATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014
ATRIAL FIBRILLATION RATE VS RHYTHM CONTROL NCVH BIRMINGHAM 2014 Facts 4 million or so people have atrial fibrillation 16 billion dollars spent yearly in USA 30% of strokes attributable to AF and AFL 3-5
More informationRadiofrequency Ablation for Atrial Fibrillation. A Guide for Adults
Radiofrequency Ablation for Atrial Fibrillation A Guide for Adults Fast Facts n There are different ways to treat atrial fibrillation (A-fib). One kind of treatment involves putting the heart back into
More informationContact force technology in catheter ablation of atrial fibrillation
Contact force technology in catheter ablation of atrial fibrillation Anna Wysocka 1, Maciej Wójcik 2 1 Chair of Internal Medicine and Department of Internal Medicine in Nursing, Medical University, Lublin,
More informationNon-surgical treatment of severe varicose veins
Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in
More informationPulmonary Vein İsolation with the Cryoballoon: Simpler, Faster But Equally Effective?
Pulmonary Vein İsolation with the Cryoballoon: Simpler, Faster But Equally Effective? Gian Battista Chierchia M.D., Antonio Sorgente M.D., Fatih Bayrak M.D., Andrea Sarkozy M.D., Carlo De Asmundis M.D.,
More informationATRIAL FIBRILLATION: Scope of the Problem. October 2015
ATRIAL FIBRILLATION: Scope of the Problem October 2015 Purpose of the Presentation Review the worldwide incidence and prognosis associated with atrial fibrillation (AF) Identify the types of AF, clinical
More informationNational Medicines Information Centre
National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 www.nmic.ie THE CONTEMPORARY MANAGEMENT OF ATRIAL FIBRILLATION VOLUME 12 NUMBER 3 2006
More informationAtrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital
Atrial Fibrillation: A Different Perspective Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Faculty/Presenter Disclosure Faculty: Dr. Michael Heffernan Relationships with commercial
More informationNone. Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management. 76 year old male LINGO 1/5/2015
Financial Disclosure Information Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management Robert D. McBane, M.D. Division of Cardiology Mayo Clinic Rochester Dual Antiplatelet
More informationSECTION I: Request. SECTION II: Need. Program Description
SECTION I: Request This is a formal request for the Utah CARMA Center to be formally recognized by the University of Utah as a large, collaborative medical and academic center whose focus is on comprehensive
More informationCurrent Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose
Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.
More informationAnticoagulation: Stroke Prevention in Patients with Atrial Fibrillation
Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation Albert L.Waldo, MD KEYWORDS Atrial fibrillation Oral anticoagulation Stroke risk EPIDEMIOLOGY OF STROKE RISK It is well recognized
More information1/7/2012. Objectives. Epidemiology of Atrial Fibrillation(AF) Stroke in AF. Stroke Risk Stratification in AF
Objectives Atrial Fibrillation and Prevention of Thrombotic Complications: Therapeutic Update Andrea C. Flores Pharm.D Pharmacy Resident at the Miami VA Healthcare System Review the epidemiology, pathophysiology
More informationIl loop recorder esterno. Roberto Maggi
Il loop recorder esterno Roberto Maggi ECG monitoring and syncope In-hospital monitoring Holter Monitoring Event recorder External loop recorder Remote (at home) telemetry Implantable loop recorder External
More informationFrederik Meijer Heart & Vascular Institute
Frederik Meijer Heart & Vascular Institute Evaluation of Atrial Fibrillation in the Outpatient Setting Musa I Dahu, MD, FHRS Electrophysiology Frederik Meijer Heart & Vascular Institute Clinical Assistant
More informationANTICOAGULATION IN ATRIAL FIBRILLATION. Heather Kertland St Michael s Hospital University of Toronto
ANTICOAGULATION IN ATRIAL FIBRILLATION Heather Kertland St Michael s Hospital University of Toronto Susan A 73 year old female admitted to the general medicine ward with pneumonia. She had been feeling
More informationPRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia
PRACTICAL APPROACH TO SVT Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia CONDUCTION SYSTEM OF THE HEART SA node His bundle Left bundle AV node Right
More informationNew Anticoagulants and GI bleeding
New Anticoagulants and GI bleeding DR DANNY MYERS MD FRCP(C) CLINICAL ASSISTANT PROFESSOR OF MEDICINE, UBC Conflicts of Interest None I am unbiased in the use of NOAC s vs Warfarin based on risk benefit
More informationAnticoagulants in Atrial Fibrillation
Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives
More informationAtrial Fibrillation (AF) Explained
James Paget University Hospitals NHS Foundation Trust Atrial Fibrillation (AF) Explained Patient Information Contents What are the symptoms of atrial fibrillation (AF)? 3 Normal heartbeat 4 How common
More informationDiagnostic Electrophysiology & Ablation
Limited Ablation for Persistent Atrial Fibrillation Using Preprocedure Reverse Remodelling David Slotwiner 1 and Jonathan Steinberg 2 1. Assistant Professor of Cardiology, Hofstra North Shore-LIJ School
More informationAdvances in the Treatment of Atrial Fibrillation At VCU Medical Center
Contact Us For additional information or to schedule an appointment with one of our specialists, please call: Ken Ellenbogen, M.D. Cardiology/Electrophysiology 804-828-7565 or 804-628-0147 You can also
More information1. Introduction. Correspondence should be addressed to Firat Duru; firat.duru@usz.ch
Cardiology Research and Practice, Article ID 179632, 8 pages http://dx.doi.org/1.1155/214/179632 Clinical Study Characterization of Pulmonary Vein Dimensions Using High-Definition 64-Slice Computed Tomography
More information5 MILLION AMERICANS 1. Atrial Fibrillation (AFib) AFib affects an estimated
A Patient s Guide To with Atrial Fibrillation (AFib) CAUSES RISK FACTORS SYMPTOMS DIAGNOSIS TREATMENTS INSIDE The Healthy Heart... 2 Your Heart In AFib... 4 How Do You Get It?... 6 How Do You Know If You
More informationObjectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History
Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize
More informationHealth Policy Advisory Committee on Technology
Health Policy Advisory Committee on Technology Technology Brief Catheter ablation for atrial fibrillation July 2014 State of Queensland (Queensland Department of Health) 2014 This work is licensed under
More information9/5/14. Objectives. Atrial Fibrillation (AF)
Novel Anticoagulation for Prevention of Stroke in Patients with Atrial Fibrillation Objectives 1. Review current evidence on use of warfarin in individuals with atrial fibrillation 2. Compare the three
More informationWhat Should be the Primary Treatment in Atrial Fibrillation: Ventricular Rate Control or Sinus Rhythm Control with Long-term Anticoagulation?
The Journal of International Medical Research 2009; 37: 464 471 What Should be the Primary Treatment in Atrial Fibrillation: Ventricular Rate Control or Sinus Rhythm Control with Long-term Anticoagulation?
More informationProtocol. Catheter Ablation as Treatment for Atrial Fibrillation
Protocol Catheter Ablation as Treatment for Atrial Fibrillation (20219) (Formerly Catheter Ablation of the Pulmonary Veins as Treatment for Atrial Fibrillation) Medical Benefit Effective Date: 10/01/15
More informationUNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD. Ex parte VINOD SHARMA and DANIEL C. SIGG
UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte VINOD SHARMA and DANIEL C. SIGG Appeal 2012-000284 Technology Center 1600 Before ERIC GRIMES, FRANCISCO C. PRATS,
More informationAtrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation
Quick reference guide Issue date: June 2006 Atrial fibrillation The management of atrial fibrillation Developed by the National Collaborating Centre for Chronic Conditions Contents Contents Patient-centred
More information